- Home
- BCML vs ZBIO Comparison
BCML vs ZBIO Comparison
Compare BCML & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- ZBIO
- Stock Information
- Founded
- BCML 2004
- ZBIO 2019
- Country
- BCML United States
- ZBIO United States
- Employees
- BCML N/A
- ZBIO N/A
- Industry
- BCML Major Banks
- ZBIO
- Sector
- BCML Finance
- ZBIO
- Exchange
- BCML Nasdaq
- ZBIO NYSE
- Market Cap
- BCML 279.0M
- ZBIO 268.7M
- IPO Year
- BCML N/A
- ZBIO 2024
- Fundamental
- Price
- BCML $24.95
- ZBIO $8.33
- Analyst Decision
- BCML
- ZBIO Strong Buy
- Analyst Count
- BCML 0
- ZBIO 6
- Target Price
- BCML N/A
- ZBIO $31.83
- AVG Volume (30 Days)
- BCML 18.8K
- ZBIO 129.7K
- Earning Date
- BCML 04-17-2025
- ZBIO 05-16-2025
- Dividend Yield
- BCML 2.38%
- ZBIO N/A
- EPS Growth
- BCML N/A
- ZBIO N/A
- EPS
- BCML 2.10
- ZBIO N/A
- Revenue
- BCML $96,253,000.00
- ZBIO $5,000,000.00
- Revenue This Year
- BCML $3.69
- ZBIO N/A
- Revenue Next Year
- BCML $6.08
- ZBIO N/A
- P/E Ratio
- BCML $12.04
- ZBIO N/A
- Revenue Growth
- BCML N/A
- ZBIO N/A
- 52 Week Low
- BCML $18.54
- ZBIO $5.83
- 52 Week High
- BCML $30.13
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- BCML 38.33
- ZBIO N/A
- Support Level
- BCML $24.37
- ZBIO N/A
- Resistance Level
- BCML $26.39
- ZBIO N/A
- Average True Range (ATR)
- BCML 0.73
- ZBIO 0.00
- MACD
- BCML -0.01
- ZBIO 0.00
- Stochastic Oscillator
- BCML 26.82
- ZBIO 0.00
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.